trial · primary record
Placebo
Paroxysmal Nocturnal Hemoglobinuria (PNH)
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2023-09-18 |
| Primary endpoint | Part 1: Change From Baseline in Hemoglobin at Week 12 |
| Registry ID | NCT05116787 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:11.783Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05116787
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound